Data further examines Seroquel (quetiapine fumarate) treatment for bipolar depression

WILMINGTON, Del, Tuesday May 24 2005 AstraZeneca (NYSE: AZN) today announced additional findings at the annual meeting of the American Psychiatric Association (APA) from the BOLDER (BipOLar DEpRession) trial, a large-scale study that examined SEROQUEL as a treatment for depressive episodes in patients with bipolar I and II disorders. Results from this trial showed SEROQUEL (600 mg/day and 300 mg/day) significantly improved quality of life measures on the Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q SF). 1

SEROQUEL is approved for the treatment of acute manic episodes associated with bipolar I disorder and for the treatment of schizophrenia. SEROQUEL is currently under investigation for use in the treatment of bipolar depression.

"The depressive phase of bipolar disorder, which patients experience approximately three times as often as the manic phase, is associated with significant impairment in quality of life. Quality of life is of critical importance for patients with bipolar disorder because they often experience relationship and work problems," said Jean Endicott, Ph.D., professor of Clinical Psychology in the Department of Psychiatry at Columbia University and Chief of the Department of Research Assessment and Training at the New York State Psychiatric Institute. "These data from the BOLDER trial are important because they recognize that quality of life is a key dimension of treatment in bipolar disorder."

The BOLDER study, an eight-week, double-blind, placebo-controlled trial, assessed SEROQUEL 300 mg/day and 600 mg/day versus placebo for the treatment of depression in 542 patients with bipolar I and II disorders. Data presented today analyzed quality of life in these patients using the Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q SF), a 16 item, self-report survey that measures differences in the degree of enjoyment and satisfaction among groups of patients, as well as changes ov


Page: 1 2 3 4

Related medicine news :

1. Stomach cancer rate set to fall further 25 percent over next decade
2. Acrux and Oreganon further expand their collaboration
3. High tech help to prevent further heart disease
4. Altered activity in receptor pair points to further complexity in schizophrenia pathology
5. Mount Sinai and YAI/NIPD Network join forces to further quality of care for people with autism
6. New study examines effectiveness of tailored health messages
7. Study examines characteristics of female high school students who report steroid use
8. Study examines genetic factors associated with head and neck cancer
9. Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors
10. MGH study examines impact of infection with both HIV and hepatitis C virus
11. Columbia study examines ADHDs role in smoking

Post Your Comments:

(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
Cached News: